Argireline

Argireline (Acetyl Hexapeptide-8) is a synthetic hexapeptide used topically to reduce the appearance of expression lines and wrinkles. It is a fragment of SNAP-25, a protein involved in neurotransmitter vesicle docking, and is marketed as a topical alternative to botulinum toxin injections. It is one of the most studied cosmetic signal peptides.

Argireline competitively inhibits the formation of the SNARE complex — the protein assembly responsible for synaptic vesicle fusion and acetylcholine release at the neuromuscular junction. By mimicking the N-terminal portion of SNAP-25, it interferes with catecholamine secretion and reduces repetitive facial muscle contractions that cause dynamic wrinkles. Unlike botulinum toxin, which cleaves SNAP-25 irreversibly, Argireline's inhibition is reversible and topically limited, with no systemic neuromuscular blockade observed at cosmetic concentrations.

Clinical studies report statistically significant reductions in wrinkle depth and length with twice-daily topical application at concentrations of 5–10% over 4–8 weeks. A double-blind RCT showed up to 27% reduction in wrinkle depth versus vehicle control. CIR safety panels have assessed Acetyl Hexapeptide-8 as non-toxic and non-comedogenic. No systemic absorption or adverse neurological effects have been documented in published human studies.

Peptides commonly paired with Argireline for synergistic effects.